NCT04830215View on ClinicalTrials.gov

Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

May 27, 2022

Study Completion Date

May 27, 2022

Conditions
Major Depressive Disorder
Interventions
DRUG

Brexpiprazole

Oral brexpiprazole tablets as adjunctive therapy to ADT

Trial Locations (1)

N7L 1C1

Chatham-Kent Clinical Trials Research Centre, Chatham

Sponsors
All Listed Sponsors
collaborator

Lundbeck Canada Inc.

INDUSTRY

collaborator

Otsuka Canada Pharmaceutical Inc.

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY